Cleveland BioLabs: Clinical Trials

2 trials sponsored by Cleveland BioLabs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1

Follow Cleveland BioLabs: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
quinacrine - Renal Cell Carcinoma
Phase 2WithdrawnCleveland BioLabs2007-11-012015-08-03
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
Quinacrine - Prostatic Cancer
Phase 2CompletedCleveland BioLabs312006-12-012013-04-11

Conditions studied

Carcinoma, Renal Cell (1)  ·  Prostatic Neoplasms (1)

Interventions

Quinacrine (2)

Countries

United States (1)

Top investigators

Edwin Posadas, MD (1)  ·  John H Gordon, PhD (1)